Simplex Trading
SLNO

Simplex Trading’s Soleno Therapeutics SLNO Stock Holding History

Simplex Trading’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.77M Sell
53,000
-54,000
-50% -$2.12M ﹤0.01% 1927
2025
Q4 		$4.95M Buy
107,000
+47,100
+79% +$2.58M ﹤0.01% 1271
2025
Q3 		$4.05M Buy
59,900
+33,200
+124% +$2.46M ﹤0.01% 1666
2025
Q2 		$2.24M Sell
26,700
-33,500
-56% -$2.51M ﹤0.01% 1993
2025
Q1 		$4.3M Buy
60,200
+15,100
+33% +$735K ﹤0.01% 1407
2024
Q4 		$2.03M Buy
45,100
+41,300
+1,087% +$2.14M ﹤0.01% 2181
2024
Q3 		$191K Buy
3,800
+1,500
+65% +$71.8K ﹤0.01% 4562
2024
Q2 		$93K Buy
2,300
+1,600
+229% +$67.8K ﹤0.01% 5452
2024
Q1 		$29K Sell
700
-19,300
-97% -$873K ﹤0.01% 6783
2023
Q4 		$805K Buy
+20,000
New +$569K ﹤0.01% 3222
2021
Q4 		– Sell
-12,753
Closed -$214K – 11349
2021
Q3 		$214K Hold
12,753
– – ﹤0.01% 5490
2021
Q2 		$218K Buy
12,753
+12,732
+60,629% +$215K ﹤0.01% 5555
2021
Q1 		$39K Sell
21
-1
-5% -$32 ﹤0.01% 6885
2020
Q4 		$64K Buy
22
+21
+2,100% +$606 ﹤0.01% 5913
2020
Q3 		$3K Hold
1
– – ﹤0.01% 7318
2020
Q2 		$1K Buy
+1
New +$43 ﹤0.01% 7403

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

Simplex Trading's SLNO Position: Q1 2026 in Review

Simplex Trading reduced its Soleno Therapeutics (SLNO) stake by 63% in Q1 2026, selling an estimated $1.21M and leaving 18,166 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #3044.

Simplex Trading first reported a position in SLNO in Q4 2020 and has held it in 10 quarters since. The position peaked at $2.27M in Q4 2025. 225 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • Simplex Trading held 18,166 shares of Soleno Therapeutics worth $608K as of Q1 2026.
  • Simplex Trading sold 30,942 Soleno Therapeutics shares in Q1 2026, an estimated $1.21M.
  • Soleno Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3044 holding.
  • Simplex Trading first reported a position in Soleno Therapeutics in Q4 2020 and has held it in 10 quarters since.
  • Simplex Trading's Soleno Therapeutics position peaked at $2.27M in Q4 2025.
  • 225 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.